-+ 0.00%
-+ 0.00%
-+ 0.00%

SciSparc Announced That Its Collaboration With Clearmind Medicine Has Led To The Publication Of A European Patent Application By The European Patent Office

Benzinga·05/12/2025 11:36:49
Listen to the news

The patent application relates to a combination treatment using Clearmind's 5-methoxy-2-aminoindane ("MEAI") and SciSparc's Palmitoylethanolamide for the treatment of cocaine addiction.